The Effect of the Combined Administration of Colloids and Lactated Ringer’s Solution on the Coagulation System: An In Vitro Study Using Thrombelastograph® Coagulation Analysis (ROTEG®)
- 1 May 2002
- journal article
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 94 (5) , 1280-1287
- https://doi.org/10.1097/00000539-200205000-00043
Abstract
Gelatin solutions are often given in clinical practice once the maximal dose of a median-weight hydroxyethyl starch (HES) has been reached. Colloids are usually combined with lactated Ringer's solution (RL). Whether the combined administration of colloids and/or crystalloids affects blood coagulation is not known. We diluted blood by 20%, 40%, and 60% with RL, gelatin (Gelofusin), 6% HES 130/0.4 (Voluven), and 6% HES 200/0.5 (Iso-Hes), as well as with combinations of these solutions at a ratio of 1:1 (gelatin/RL, 6% HES 130/0.4:RL, 6% HES 200/0.5:RL, 6% HES 130/0.4:gelatin, 6% HES 200/0.5:gelatin). Thereafter, blood was analyzed by using modified thrombelastograph coagulation analysis (ROTEG) and clotting time, clot formation time, and maximal clot firmness were determined. RL had the least effect on hemostasis. Gelatin administered alone impaired the coagulation system significantly less than each median-weight HES administered alone. We conclude that gelatin combined with 6% HES 200/0.5 or 6% HES 130/0.4 decreases hemostasis <6% HES 200/0.5 or 6% HES 130/0.4 administered alone. The effect of the combined administration of different colloids and/or crystalloids on coagulation is not known. We show that hemostasis is less impaired using a combination of gelatin and median-weight starches than using median-weight starches alone. Furthermore, the combination of lactated Ringer's solution and gelatin decreases the coagulation system to the same extent as the combination of lactated Ringer's solution and 6% hydroxyethyl starch 130/0.4.Keywords
This publication has 21 references indexed in Scilit:
- Voluven®, a Lower Substituted Novel Hydroxyethyl Starch (HES 130/0.4), Causes Fewer Effects on Coagulation in Major Orthopedic Surgery than HES 200/0.5Anesthesia & Analgesia, 2001
- A novel hydroxyethyl starch (Voluven®) for effective perioperative plasma volume substitution in cardiac surgeryCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 2000
- Coagulation effects of a recently developed hydroxyethyl starch (HES 130/0.4) compared to hydroxyethyl starches with higher molecular weightActa Anaesthesiologica Scandinavica, 2000
- RETRACTED: Volume replacement in the surgical patient—does the type of solution make a difference?British Journal of Anaesthesia, 2000
- An international view of hydroxyethyl starchesIntensive Care Medicine, 1999
- Human albumin administration in critically ill patients: systematic review of randomised controlled trials Why albumin may not workBMJ, 1998
- Reduced quality of clot formation with gelatin-based plasma substitutesBritish Journal of Anaesthesia, 1998
- Effect of progressive haemodilution with hydroxyethyl starch, gelatin and albumin on blood coagulation.British Journal of Anaesthesia, 1997
- Large-Dose Administration of 6% Hydroxyethyl Starch 200/0.5 for Total Hip ArthroplastyAnesthesia & Analgesia, 1996
- Affinity of fibronectin to collagens of different genetic types and to fibrinogen.The Journal of Experimental Medicine, 1978